Attached files
file | filename |
---|---|
8-K - 8-K - METLIFE INC | d105315d8k.htm |
EX-99.1 - EX-99.1 - METLIFE INC | d105315dex991.htm |
EX-99.3 - EX-99.3 - METLIFE INC | d105315dex993.htm |
Table of Contents
Exhibit 99.2
Fourth Quarter
Financial Supplement
December 31, 2015
Table of Contents
1
Table of Contents
METLIFE
As used in this QFS, MetLife, we and our refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. In this QFS, MetLife presents certain measures of its performance that are not calculated in accordance with GAAP. We believe that these non-GAAP financial measures enhance the understanding of our performance by highlighting the results of operations and the underlying profitability drivers of our business. See Appendix for definitions of these non-GAAP financial measures and other financial disclosures.
|
| |||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions, except per share data) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Operating earnings available to common shareholders |
$ | 1,583 | $ | 1,638 | $ | 1,765 | $ | 705 | $ | 1,376 | ||||||||||
Preferred stock dividends |
31 | 30 | 31 | 6 | 49 | |||||||||||||||
Operating earnings |
1,614 | 1,668 | 1,796 | 711 | 1,425 | |||||||||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||
Net investment gains (losses) |
230 | 286 | (133 | ) | 382 | 62 | ||||||||||||||
Net derivative gains (losses) |
185 | 821 | (912 | ) | 485 | (356 | ) | |||||||||||||
Goodwill impairment |
- | - | - | - | - | |||||||||||||||
Other adjustments to continuing operations |
(453 | ) | (310 | ) | (177 | ) | (206 | ) | (398 | ) | ||||||||||
Provision for income tax (expense) benefit |
(49 | ) | (302 | ) | 545 | (174 | ) | 109 | ||||||||||||
Income (loss) from continuing operations, net of income tax |
1,527 | 2,163 | 1,119 | 1,198 | 842 | |||||||||||||||
Income (loss) from discontinued operations, net of income tax |
- | - | - | - | - | |||||||||||||||
Net income (loss) |
1,527 | 2,163 | 1,119 | 1,198 | 842 | |||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
6 | 5 | 4 | (5 | ) | 8 | ||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
1,521 | 2,158 | 1,115 | 1,203 | 834 | |||||||||||||||
Less: Preferred stock dividends |
31 | 30 | 31 | 6 | 49 | |||||||||||||||
Preferred stock repurchase premium |
- | - | 42 | - | - | |||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders |
$ | 1,490 | $ | 2,128 | $ | 1,042 | $ | 1,197 | $ | 785 | ||||||||||
Operating earnings available to common shareholders per common share - diluted |
$ | 1.38 | $ | 1.44 | $ | 1.56 | $ | 0.62 | $ | 1.23 | ||||||||||
Net investment gains (losses) |
0.20 | 0.25 | (0.12 | ) | 0.34 | 0.06 | ||||||||||||||
Net derivative gains (losses) |
0.16 | 0.72 | (0.81 | ) | 0.43 | (0.32 | ) | |||||||||||||
Goodwill impairment |
- | - | - | - | - | |||||||||||||||
Other adjustments to continuing operations |
(0.39 | ) | (0.27 | ) | (0.15 | ) | (0.18 | ) | (0.36 | ) | ||||||||||
Provision for income tax (expense) benefit |
(0.04 | ) | (0.27 | ) | 0.48 | (0.15 | ) | 0.10 | ||||||||||||
Discontinued operations, net of income tax |
- | - | - | - | - | |||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
0.01 | - | - | - | 0.01 | |||||||||||||||
Preferred stock repurchase premium |
- | - | 0.04 | - | - | |||||||||||||||
Net income (loss) available to MetLife, Inc.'s common shareholders per common share - diluted |
$ | 1.30 | $ | 1.87 | $ | 0.92 | $ | 1.06 | $ | 0.70 | ||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions, except per share data) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Notable items impacting operating earnings available to common shareholders: |
||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (37 | ) | $ | (137 | ) | ||||||||
Catastrophe experience and prior year development, net |
16 | (16 | ) | - | 21 | (9 | ) | |||||||||||||
Actuarial assumption review and other insurance adjustments |
5 | - | - | (92 | ) | - | ||||||||||||||
Litigation reserves & settlement costs |
(117 | ) | - | - | - | - | ||||||||||||||
Tax adjustments |
27 | - | 61 | (720 | ) | 31 | ||||||||||||||
Total notable items (1) |
$ | (69 | ) | $ | (16 | ) | $ | 61 | $ | (828 | ) | $ | (115) | |||||||
Notable items impacting operating earnings available to common shareholders per common share - diluted: |
||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (0.03 | ) | $ | (0.12 | ) | ||||||||
Catastrophe experience and prior year development, net |
$ | 0.01 | $ | (0.01 | ) | $ | - | $ | 0.02 | $ | (0.01 | ) | ||||||||
Actuarial assumption review and other insurance adjustments |
$ | - | $ | - | $ | - | $ | (0.08 | ) | $ | - | |||||||||
Litigation reserves & settlement costs |
$ | (0.10 | ) | $ | - | $ | - | $ | - | $ | - | |||||||||
Tax adjustments |
$ | 0.02 | $ | - | $ | 0.05 | $ | (0.64 | ) | $ | 0.03 | |||||||||
Total notable items (1) |
$ | (0.06 | ) | $ | (0.01 | ) | $ | 0.05 | $ | (0.73 | ) | $ | (0.10 | ) | ||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Weighted average common shares outstanding - diluted |
1,147.3 | 1,135.8 | 1,128.4 | 1,129.9 | 1,121.4 | |||||||||||||||
(1) Notable items represent a positive (negative) impact to operating earnings available to common shareholders and operating earnings available to common shareholders per common share - diluted. The per share data for each notable item is calculated on a stand alone basis and may not sum to total notable items. |
|
2
Table of Contents
METLIFE CORPORATE OVERVIEW (CONTINUED)
|
||||||||||||||||||||
Unaudited | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Book value per common share, excluding AOCI other than FCTA (1) |
$ | 49.53 | $ | 50.45 | $ | 50.73 | $ | 51.11 | $ | 51.15 | ||||||||||
Book value per common share - tangible common stockholders' equity (excludes AOCI other than FCTA) (1) |
$ | 40.36 | $ | 41.32 | $ | 41.73 | $ | 42.21 | $ | 42.22 | ||||||||||
Book value per common share (1) |
$ | 61.85 | $ | 64.37 | $ | 60.27 | $ | 61.39 | $ | 60.00 | ||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Operating return on MetLife, Inc.'s (2): |
||||||||||||||||||||
Common stockholders' equity, excluding AOCI other than FCTA |
11.3% | 11.7% | 12.5% | 5.0% | 9.7% | |||||||||||||||
Tangible common stockholders' equity (excludes AOCI other than FCTA) |
14.1% | 14.4% | 15.3% | 6.1% | 11.9% | |||||||||||||||
Common stockholders' equity |
9.1% | 9.2% | 10.2% | 4.2% | 8.2% | |||||||||||||||
Return on MetLife, Inc.'s (2): |
||||||||||||||||||||
Common stockholders' equity, excluding AOCI other than FCTA |
10.7% | 15.2% | 7.4% | 8.4% | 5.6% | |||||||||||||||
Tangible common stockholders' equity (excludes AOCI other than FCTA) |
13.3% | 18.7% | 9.1% | 10.3% | 6.8% | |||||||||||||||
Common stockholders' equity |
8.6% | 12.0% | 6.0% | 7.1% | 4.7% | |||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Common shares outstanding, beginning of period |
1,119.1 | 1,131.9 | 1,114.3 | 1,116.8 | 1,114.8 | |||||||||||||||
Share repurchases |
(10.7 | ) | (19.9 | ) | (0.2 | ) | (2.3 | ) | (17.1 | ) | ||||||||||
Newly issued shares |
23.5 | 2.3 | 2.7 | 0.3 | 0.3 | |||||||||||||||
Common shares outstanding, end of period |
1,131.9 | 1,114.3 | 1,116.8 | 1,114.8 | 1,098.0 | |||||||||||||||
Weighted average common shares outstanding - basic |
1,135.8 | 1,125.7 | 1,117.8 | 1,118.9 | 1,110.9 | |||||||||||||||
Dilutive effect of the exercise or issuance of stock-based awards |
11.5 | 10.1 | 10.6 | 11.0 | 10.5 | |||||||||||||||
Weighted average common shares outstanding - diluted |
1,147.3 | 1,135.8 | 1,128.4 | 1,129.9 | 1,121.4 | |||||||||||||||
MetLife Policyholder Trust Shares |
180.5 | 178.3 | 175.0 | 173.2 | 171.0 | |||||||||||||||
(1) Calculated using common shares outstanding, end of period.
(2) Annualized using quarter-to-date results. See page A-4 for the operating return on MetLife, Inc.'s common stockholders' equity and return on MetLife, Inc.'s common stockholders' equity for the years ended December 31, 2014 and 2015. |
|
3
Table of Contents
|
||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
ASSETS |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities available-for-sale, at estimated fair value |
$ | 365,425 | $ | 366,275 | $ | 351,353 | $ | 351,578 | $ | 351,402 | ||||||||||
Equity securities available-for-sale, at estimated fair value |
3,631 | 3,713 | 3,677 | 3,399 | 3,321 | |||||||||||||||
Fair value option and trading securities, at estimated fair value (1) |
16,689 | 16,471 | 16,460 | 15,361 | 15,024 | |||||||||||||||
Mortgage loans |
60,118 | 62,409 | 64,010 | 63,553 | 67,102 | |||||||||||||||
Policy loans |
11,618 | 11,606 | 11,575 | 11,549 | 11,258 | |||||||||||||||
Real estate and real estate joint ventures |
10,525 | 10,310 | 10,207 | 9,923 | 8,433 | |||||||||||||||
Other limited partnership interests |
8,085 | 8,074 | 8,099 | 7,901 | 7,096 | |||||||||||||||
Short-term investments, principally at estimated fair value |
8,621 | 14,130 | 14,594 | 14,957 | 9,299 | |||||||||||||||
Other invested assets, principally at estimated fair value |
21,283 | 23,763 | 20,409 | 23,356 | 22,524 | |||||||||||||||
Total investments |
505,995 | 516,751 | 500,384 | 501,577 | 495,459 | |||||||||||||||
Cash and cash equivalents, principally at estimated fair value (1) |
10,808 | 8,127 | 8,074 | 10,216 | 12,752 | |||||||||||||||
Accrued investment income |
4,120 | 4,298 | 3,990 | 4,187 | 3,988 | |||||||||||||||
Premiums, reinsurance and other receivables |
22,244 | 24,190 | 24,872 | 25,808 | 22,702 | |||||||||||||||
Deferred policy acquisition costs and value of business acquired |
24,442 | 24,003 | 24,379 | 23,996 | 24,130 | |||||||||||||||
Current income tax recoverable |
- | - | - | - | 161 | |||||||||||||||
Goodwill |
9,872 | 9,717 | 9,644 | 9,546 | 9,477 | |||||||||||||||
Other assets |
7,862 | 7,980 | 7,589 | 7,881 | 7,666 | |||||||||||||||
Separate account assets |
316,994 | 324,724 | 319,477 | 299,249 | 301,598 | |||||||||||||||
Total assets |
$ | 902,337 | $ | 919,790 | $ | 898,409 | $ | 882,460 | $ | 877,933 | ||||||||||
LIABILITIES AND EQUITY |
||||||||||||||||||||
Liabilities |
||||||||||||||||||||
Future policy benefits |
$ | 189,586 | $ | 191,217 | $ | 188,928 | $ | 190,754 | $ | 191,879 | ||||||||||
Policyholder account balances |
209,294 | 206,591 | 204,262 | 202,291 | 202,722 | |||||||||||||||
Other policy-related balances |
14,422 | 14,586 | 14,393 | 14,521 | 14,255 | |||||||||||||||
Policyholder dividends payable |
684 | 677 | 699 | 716 | 720 | |||||||||||||||
Policyholder dividend obligation |
3,155 | 3,483 | 2,328 | 2,309 | 1,783 | |||||||||||||||
Payables for collateral under securities loaned and other transactions |
35,326 | 37,312 | 35,532 | 37,991 | 36,871 | |||||||||||||||
Short-term debt |
100 | 100 | 100 | 100 | 100 | |||||||||||||||
Long-term debt (1) |
16,286 | 17,714 | 16,770 | 16,755 | 18,023 | |||||||||||||||
Collateral financing arrangements |
4,196 | 4,196 | 4,164 | 4,152 | 4,139 | |||||||||||||||
Junior subordinated debt securities |
3,193 | 3,193 | 3,193 | 3,194 | 3,194 | |||||||||||||||
Current income tax payable |
184 | 243 | 71 | 21 | - | |||||||||||||||
Deferred income tax liability |
11,821 | 13,305 | 10,762 | 11,363 | 10,592 | |||||||||||||||
Other liabilities |
24,437 | 28,040 | 27,741 | 27,977 | 23,561 | |||||||||||||||
Separate account liabilities |
316,994 | 324,724 | 319,477 | 299,249 | 301,598 | |||||||||||||||
Total liabilities |
829,678 | 845,381 | 828,420 | 811,393 | 809,437 | |||||||||||||||
Redeemable noncontrolling interests in partially-owned consolidated subsidiaries |
99 | 95 | 92 | 79 | 77 | |||||||||||||||
Equity |
||||||||||||||||||||
Preferred stock, at par value |
1 | 1 | - | - | - | |||||||||||||||
Common stock, at par value |
12 | 12 | 12 | 12 | 12 | |||||||||||||||
Additional paid-in capital |
30,543 | 30,632 | 30,718 | 30,726 | 30,749 | |||||||||||||||
Retained earnings |
32,020 | 33,754 | 34,376 | 35,153 | 35,519 | |||||||||||||||
Treasury stock, at cost |
(1,172 | ) | (2,158 | ) | (2,172 | ) | (2,279 | ) | (3,102 | ) | ||||||||||
Accumulated other comprehensive income (loss) |
10,649 | 11,529 | 6,443 | 6,891 | 4,771 | |||||||||||||||
Total MetLife, Inc.'s stockholders' equity |
72,053 | 73,770 | 69,377 | 70,503 | 67,949 | |||||||||||||||
Noncontrolling interests |
507 | 544 | 520 | 485 | 470 | |||||||||||||||
Total equity |
72,560 | 74,314 | 69,897 | 70,988 | 68,419 | |||||||||||||||
Total liabilities and equity |
$ | 902,337 | $ | 919,790 | $ | 898,409 | $ | 882,460 | $ | 877,933 | ||||||||||
(1) At December 31, 2014, March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015, $295 million, $287 million, $280 million, $218 million and $184 million, respectively, of assets and $151 million, $143 million, $134 million, $72 million and $60 million, respectively, of liabilities related to certain securitization entities that are required to be consolidated under GAAP are included. See Pages 30 and 31, note 3, for the amounts by asset category. |
|
4
Table of Contents
5
Table of Contents
6
Table of Contents
METLIFE CONSOLIDATING STATEMENT OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
|
| |||||||||||||||||||
For the Three Months Ended December 31, 2014 | ||||||||||||||||||||
Unaudited (In millions) | Consolidated | Americas | Asia | EMEA | Corporate & Other | |||||||||||||||
Operating revenues |
||||||||||||||||||||
Premiums |
$ | 10,267 | $ | 7,880 | $ | 1,824 | $ | 547 | $ | 16 | ||||||||||
Universal life and investment-type product policy fees |
2,336 | 1,775 | 417 | 113 | 31 | |||||||||||||||
Net investment income |
5,111 | 4,185 | 724 | 100 | 102 | |||||||||||||||
Other revenues |
531 | 464 | 28 | 11 | 28 | |||||||||||||||
Total operating revenues |
18,245 | 14,304 | 2,993 | 771 | 177 | |||||||||||||||
Operating expenses |
||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
10,287 | 8,647 | 1,367 | 269 | 4 | |||||||||||||||
Interest credited to policyholder account balances |
1,409 | 996 | 369 | 36 | 8 | |||||||||||||||
Capitalization of DAC |
(1,034 | ) | (409 | ) | (456 | ) | (169 | ) | - | |||||||||||
Amortization of DAC and VOBA |
953 | 486 | 330 | 137 | - | |||||||||||||||
Amortization of negative VOBA |
(98 | ) | - | (89 | ) | (9 | ) | - | ||||||||||||
Interest expense on debt |
293 | 6 | - | - | 287 | |||||||||||||||
Other expenses |
4,321 | 2,499 | 980 | 463 | 379 | |||||||||||||||
Total operating expenses |
16,131 | 12,225 | 2,501 | 727 | 678 | |||||||||||||||
Operating earnings before provision for income tax |
2,114 | 2,079 | 492 | 44 | (501 | ) | ||||||||||||||
Provision for income tax expense (benefit) |
500 | 611 | 152 | (20 | ) | (243 | ) | |||||||||||||
Operating earnings |
1,614 | 1,468 | 340 | 64 | (258 | ) | ||||||||||||||
Preferred stock dividends |
31 | - | - | - | 31 | |||||||||||||||
Operating earnings available to common shareholders |
$ | 1,583 | $ | 1,468 | $ | 340 | $ | 64 | $ | (289 | ) | |||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||
Operating earnings |
$ | 1,614 | $ | 1,468 | $ | 340 | $ | 64 | $ | (258 | ) | |||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||
Net investment gains (losses) |
230 | 82 | 137 | (1 | ) | 12 | ||||||||||||||
Net derivative gains (losses) |
185 | 310 | (410 | ) | 11 | 274 | ||||||||||||||
Premiums |
5 | (1 | ) | - | 6 | - | ||||||||||||||
Universal life and investment-type product policy fees |
103 | 97 | 3 | 3 | - | |||||||||||||||
Net investment income |
338 | (181 | ) | 281 | 231 | 7 | ||||||||||||||
Other revenues |
13 | - | (5 | ) | - | 18 | ||||||||||||||
Policyholder benefits and claims and policyholder dividends |
(320 | ) | (242 | ) | (75 | ) | (3 | ) | - | |||||||||||
Interest credited to policyholder account balances |
(539 | ) | (24 | ) | (289 | ) | (226 | ) | - | |||||||||||
Capitalization of DAC |
- | - | - | - | - | |||||||||||||||
Amortization of DAC and VOBA |
(5 | ) | - | (2 | ) | (3 | ) | - | ||||||||||||
Amortization of negative VOBA |
11 | - | 11 | - | - | |||||||||||||||
Interest expense on debt |
(4 | ) | - | - | - | (4 | ) | |||||||||||||
Other expenses |
(55 | ) | 3 | 4 | (3 | ) | (59 | ) | ||||||||||||
Goodwill impairment |
- | - | - | - | - | |||||||||||||||
Provision for income tax (expense) benefit |
(49 | ) | (25 | ) | 99 | (28 | ) | (95 | ) | |||||||||||
Income (loss) from continuing operations, net of income tax |
1,527 | 1,487 | 94 | 51 | (105 | ) | ||||||||||||||
Income (loss) from discontinued operations, net of income tax |
- | - | - | - | - | |||||||||||||||
Net income (loss) |
1,527 | 1,487 | 94 | 51 | (105 | ) | ||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
6 | 2 | 4 | (1 | ) | 1 | ||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
1,521 | 1,485 | 90 | 52 | (106 | ) | ||||||||||||||
Less: Preferred stock dividends |
31 | - | - | - | 31 | |||||||||||||||
Preferred stock repurchase premium |
- | - | - | - | - | |||||||||||||||
Net income (loss) available to MetLife, Inc.s common shareholders |
$ | 1,490 | $ | 1,485 | $ | 90 | $ | 52 | $ | (137 | ) | |||||||||
Total Operating Premiums, Fees and Other Revenues |
$ | 13,134 | $ | 10,119 | $ | 2,269 | $ | 671 | $ | 75 |
7
Table of Contents
METLIFE CONSOLIDATING STATEMENT OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
|
| |||||||||||||||||||
For the Year Ended December 31, 2015 | ||||||||||||||||||||
Unaudited (In millions) | Consolidated | Americas | Asia | EMEA | Corporate & Other | |||||||||||||||
Operating revenues |
||||||||||||||||||||
Premiums |
$ | 38,548 | $ | 29,496 | $ | 6,937 | $ | 2,036 | $ | 79 | ||||||||||
Universal life and investment-type product policy fees |
9,113 | 7,048 | 1,542 | 424 | 99 | |||||||||||||||
Net investment income |
19,789 | 16,469 | 2,675 | 326 | 319 | |||||||||||||||
Other revenues |
2,020 | 1,768 | 105 | 61 | 86 | |||||||||||||||
Total operating revenues |
69,470 | 54,781 | 11,259 | 2,847 | 583 | |||||||||||||||
Operating expenses |
||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
39,565 | 33,237 | 5,275 | 988 | 65 | |||||||||||||||
Interest credited to policyholder account balances |
5,334 | 3,882 | 1,309 | 120 | 23 | |||||||||||||||
Capitalization of DAC |
(3,837 | ) | (1,644 | ) | (1,720 | ) | (472 | ) | (1 | ) | ||||||||||
Amortization of DAC and VOBA |
3,802 | 2,049 | 1,256 | 497 | - | |||||||||||||||
Amortization of negative VOBA |
(326 | ) | (1 | ) | (309 | ) | (16 | ) | - | |||||||||||
Interest expense on debt |
1,200 | 2 | - | - | 1,198 | |||||||||||||||
Other expenses (1) |
15,806 | 9,736 | 3,611 | 1,469 | 990 | |||||||||||||||
Total operating expenses |
61,544 | 47,261 | 9,422 | 2,586 | 2,275 | |||||||||||||||
Operating earnings before provision for income tax |
7,926 | 7,520 | 1,837 | 261 | (1,692 | ) | ||||||||||||||
Provision for income tax expense (benefit) (1) |
2,326 | 2,201 | 457 | 21 | (353 | ) | ||||||||||||||
Operating earnings |
5,600 | 5,319 | 1,380 | 240 | (1,339 | ) | ||||||||||||||
Preferred stock dividends |
116 | - | - | - | 116 | |||||||||||||||
Operating earnings available to common shareholders |
$ | 5,484 | $ | 5,319 | $ | 1,380 | $ | 240 | $ | (1,455 | ) | |||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||
Operating earnings |
$ | 5,600 | $ | 5,319 | $ | 1,380 | $ | 240 | $ | (1,339 | ) | |||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||
Net investment gains (losses) |
597 | 399 | 501 | 27 | (330 | ) | ||||||||||||||
Net derivative gains (losses) |
38 | (100 | ) | 67 | 40 | 31 | ||||||||||||||
Premiums |
(3 | ) | (3 | ) | - | - | - | |||||||||||||
Universal life and investment-type product policy fees |
394 | 387 | 12 | (5 | ) | - | ||||||||||||||
Net investment income |
(508 | ) | (723 | ) | 184 | 21 | 10 | |||||||||||||
Other revenues |
(37 | ) | - | (37 | ) | - | - | |||||||||||||
Policyholder benefits and claims and policyholder dividends |
(537 | ) | (425 | ) | (112 | ) | - | - | ||||||||||||
Interest credited to policyholder account balances |
(276 | ) | (61 | ) | (197 | ) | (18 | ) | - | |||||||||||
Capitalization of DAC |
- | - | - | - | - | |||||||||||||||
Amortization of DAC and VOBA |
(134 | ) | (130 | ) | (9 | ) | 5 | - | ||||||||||||
Amortization of negative VOBA |
35 | - | 35 | - | - | |||||||||||||||
Interest expense on debt |
(8 | ) | - | - | - | (8 | ) | |||||||||||||
Other expenses |
(17 | ) | 12 | 4 | - | (33 | ) | |||||||||||||
Goodwill impairment |
- | - | - | - | - | |||||||||||||||
Provision for income tax (expense) benefit |
178 | 120 | (21 | ) | (22 | ) | 101 | |||||||||||||
Income (loss) from continuing operations, net of income tax |
5,322 | 4,795 | 1,807 | 288 | (1,568 | ) | ||||||||||||||
Income (loss) from discontinued operations, net of income tax |
- | - | - | - | - | |||||||||||||||
Net income (loss) |
5,322 | 4,795 | 1,807 | 288 | (1,568 | ) | ||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
12 | 11 | 4 | 4 | (7 | ) | ||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
5,310 | 4,784 | 1,803 | 284 | (1,561 | ) | ||||||||||||||
Less: Preferred stock dividends |
116 | - | - | - | 116 | |||||||||||||||
Preferred stock repurchase premium |
42 | - | - | - | 42 | |||||||||||||||
Net income (loss) available to MetLife, Inc.s common shareholders |
$ | 5,152 | $ | 4,784 | $ | 1,803 | $ | 284 | $ | (1,719 | ) | |||||||||
Total Operating Premiums, Fees and Other Revenues |
$ | 49,681 | $ | 38,312 | $ | 8,584 | $ | 2,521 | $ | 264 | ||||||||||
(1) Consolidated and Corporate & Other results include a non-cash charge of $792 million, net of tax, related to an uncertain tax position comprised of a $557 million charge included in provision for income tax expense (benefit) and a $362 million charge, $235 million net of tax, included in other expenses. See notable items on pages A-2 and A-3. |
|
8
Table of Contents
METLIFE CONSOLIDATING STATEMENT OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
|
| |||||||||||||||||||
For the Year Ended December 31, 2014 | ||||||||||||||||||||
Unaudited (In millions) | Consolidated | Americas | Asia | EMEA | Corporate & Other | |||||||||||||||
Operating revenues |
||||||||||||||||||||
Premiums |
$ | 39,022 | $ | 29,066 | $ | 7,566 | $ | 2,309 | $ | 81 | ||||||||||
Universal life and investment-type product policy fees |
9,541 | 7,255 | 1,693 | 466 | 127 | |||||||||||||||
Net investment income |
20,484 | 16,661 | 2,886 | 428 | 509 | |||||||||||||||
Other revenues |
2,033 | 1,800 | 106 | 60 | 67 | |||||||||||||||
Total operating revenues |
71,080 | 54,782 | 12,251 | 3,263 | 784 | |||||||||||||||
Operating expenses |
||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
39,478 | 32,640 | 5,724 | 1,053 | 61 | |||||||||||||||
Interest credited to policyholder account balances |
5,661 | 3,935 | 1,544 | 148 | 34 | |||||||||||||||
Capitalization of DAC |
(4,182 | ) | (1,588 | ) | (1,914 | ) | (680 | ) | - | |||||||||||
Amortization of DAC and VOBA |
4,027 | 2,017 | 1,397 | 613 | - | |||||||||||||||
Amortization of negative VOBA |
(396 | ) | (1 | ) | (364 | ) | (31 | ) | - | |||||||||||
Interest expense on debt |
1,178 | 11 | - | - | 1,167 | |||||||||||||||
Other expenses |
16,254 | 9,584 | 3,975 | 1,846 | 849 | |||||||||||||||
Total operating expenses |
62,020 | 46,598 | 10,362 | 2,949 | 2,111 | |||||||||||||||
Operating earnings before provision for income tax |
9,060 | 8,184 | 1,889 | 314 | (1,327 | ) | ||||||||||||||
Provision for income tax expense (benefit) |
2,378 | 2,464 | 582 | 29 | (697 | ) | ||||||||||||||
Operating earnings |
6,682 | 5,720 | 1,307 | 285 | (630 | ) | ||||||||||||||
Preferred stock dividends |
122 | - | - | - | 122 | |||||||||||||||
Operating earnings available to common shareholders |
$ | 6,560 | $ | 5,720 | $ | 1,307 | $ | 285 | $ | (752 | ) | |||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||
Operating earnings |
$ | 6,682 | $ | 5,720 | $ | 1,307 | $ | 285 | $ | (630 | ) | |||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||
Net investment gains (losses) (1) |
(197 | ) | (448 | ) | 512 | (17 | ) | (244 | ) | |||||||||||
Net derivative gains (losses) |
1,317 | 1,381 | (532 | ) | 114 | 354 | ||||||||||||||
Premiums |
45 | (1 | ) | - | 46 | - | ||||||||||||||
Universal life and investment-type product policy fees |
405 | 383 | 11 | 11 | - | |||||||||||||||
Net investment income |
669 | (571 | ) | 393 | 810 | 37 | ||||||||||||||
Other revenues |
(3 | ) | 1 | (22 | ) | - | 18 | |||||||||||||
Policyholder benefits and claims and policyholder dividends |
(1,000 | ) | (809 | ) | (170 | ) | (21 | ) | - | |||||||||||
Interest credited to policyholder account balances |
(1,282 | ) | (100 | ) | (403 | ) | (779 | ) | - | |||||||||||
Capitalization of DAC |
1 | - | - | 1 | - | |||||||||||||||
Amortization of DAC and VOBA |
(105 | ) | (95 | ) | 3 | (13 | ) | - | ||||||||||||
Amortization of negative VOBA |
46 | - | 46 | - | - | |||||||||||||||
Interest expense on debt |
(38 | ) | - | - | - | (38 | ) | |||||||||||||
Other expenses |
(114 | ) | - | 20 | (19 | ) | (115 | ) | ||||||||||||
Goodwill impairment |
- | - | - | - | - | |||||||||||||||
Provision for income tax (expense) benefit |
(87 | ) | 31 | 35 | (88 | ) | (65 | ) | ||||||||||||
Income (loss) from continuing operations, net of income tax |
6,339 | 5,492 | 1,200 | 330 | (683 | ) | ||||||||||||||
Income (loss) from discontinued operations, net of income tax |
(3 | ) | (3 | ) | - | - | - | |||||||||||||
Net income (loss) |
6,336 | 5,489 | 1,200 | 330 | (683 | ) | ||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
27 | 13 | 19 | 1 | (6 | ) | ||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
6,309 | 5,476 | 1,181 | 329 | (677 | ) | ||||||||||||||
Less: Preferred stock dividends |
122 | - | - | - | 122 | |||||||||||||||
Preferred stock repurchase premium |
- | - | - | - | - | |||||||||||||||
Net income (loss) available to MetLife, Inc.s common shareholders |
$ | 6,187 | $ | 5,476 | $ | 1,181 | $ | 329 | $ | (799 | ) | |||||||||
Total Operating Premiums, Fees and Other Revenues |
$ | 50,596 | $ | 38,121 | $ | 9,365 | $ | 2,835 | $ | 275 | ||||||||||
(1) Consolidated and Americas results include a pre-tax net investment loss of $633 million related to the sale of MetLife, Inc.'s wholly-owned subsidiary, MetLife Assurance Limited. |
|
9
Table of Contents
10
Table of Contents
11
Table of Contents
AMERICAS RETAIL - LIFE & OTHER STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
|
| |||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Operating revenues |
||||||||||||||||||||||||||||||
Premiums |
$ | 1,627 | $ | 1,494 | $ | 1,522 | $ | 1,521 | $ | 1,624 | $ | 6,142 | $ | 6,161 | ||||||||||||||||
Universal life and investment-type product policy fees |
402 | 392 | 384 | 395 | 402 | 1,630 | 1,573 | |||||||||||||||||||||||
Net investment income |
1,263 | 1,245 | 1,275 | 1,225 | 1,189 | 4,981 | 4,934 | |||||||||||||||||||||||
Other revenues |
166 | 144 | 153 | 139 | 123 | 622 | 559 | |||||||||||||||||||||||
Total operating revenues |
3,458 | 3,275 | 3,334 | 3,280 | 3,338 | 13,375 | 13,227 | |||||||||||||||||||||||
Operating expenses |
||||||||||||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
2,055 | 2,070 | 2,016 | 2,081 | 2,128 | 8,052 | 8,295 | |||||||||||||||||||||||
Interest credited to policyholder account balances |
229 | 227 | 230 | 234 | 239 | 904 | 930 | |||||||||||||||||||||||
Capitalization of DAC |
(163 | ) | (158 | ) | (159 | ) | (165 | ) | (164 | ) | (634 | ) | (646 | ) | ||||||||||||||||
Amortization of DAC and VOBA |
193 | 210 | 205 | 237 | 202 | 754 | 854 | |||||||||||||||||||||||
Amortization of negative VOBA |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Interest expense on debt |
1 | (1 | ) | (1 | ) | (1 | ) | 1 | (1 | ) | (2 | ) | ||||||||||||||||||
Other expenses |
648 | 632 | 634 | 626 | 648 | 2,502 | 2,540 | |||||||||||||||||||||||
Total operating expenses |
2,963 | 2,980 | 2,925 | 3,012 | 3,054 | 11,577 | 11,971 | |||||||||||||||||||||||
Operating earnings before provision for income tax |
495 | 295 | 409 | 268 | 284 | 1,798 | 1,256 | |||||||||||||||||||||||
Provision for income tax expense (benefit) |
162 | 92 | 131 | 85 | 89 | 579 | 397 | |||||||||||||||||||||||
Operating earnings |
333 | 203 | 278 | 183 | 195 | 1,219 | 859 | |||||||||||||||||||||||
Preferred stock dividends |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Operating earnings available to common shareholders |
$ | 333 | $ | 203 | $ | 278 | $ | 183 | $ | 195 | $ | 1,219 | $ | 859 | ||||||||||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||||||||||||
Operating earnings |
$ | 333 | $ | 203 | $ | 278 | $ | 183 | $ | 195 | $ | 1,219 | $ | 859 | ||||||||||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||||||||||||
Net investment gains (losses) |
(35 | ) | 1 | 19 | 42 | (89 | ) | (57 | ) | (27 | ) | |||||||||||||||||||
Net derivative gains (losses) |
119 | 186 | (110 | ) | 145 | 27 | 292 | 248 | ||||||||||||||||||||||
Premiums |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Universal life and investment-type product policy fees |
- | - | (1 | ) | 1 | (1 | ) | (1 | ) | (1 | ) | |||||||||||||||||||
Net investment income |
(57 | ) | (60 | ) | (59 | ) | (58 | ) | (60 | ) | (222 | ) | (237 | ) | ||||||||||||||||
Other revenues |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
6 | 17 | (10 | ) | (13 | ) | - | 6 | (6 | ) | ||||||||||||||||||||
Interest credited to policyholder account balances |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Capitalization of DAC |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Amortization of DAC and VOBA |
(19 | ) | (19 | ) | 24 | (68 | ) | 9 | 22 | (54 | ) | |||||||||||||||||||
Amortization of negative VOBA |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Interest expense on debt |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Other expenses |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Goodwill impairment |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Provision for income tax (expense) benefit |
(2 | ) | (44 | ) | 48 | (17 | ) | 40 | (11 | ) | 27 | |||||||||||||||||||
Income (loss) from continuing operations, net of income tax |
345 | 284 | 189 | 215 | 121 | 1,248 | 809 | |||||||||||||||||||||||
Income (loss) from discontinued operations, net of income tax |
- | - | - | - | - | (2 | ) | - | ||||||||||||||||||||||
Net income (loss) |
345 | 284 | 189 | 215 | 121 | 1,246 | 809 | |||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
345 | 284 | 189 | 215 | 121 | 1,246 | 809 | |||||||||||||||||||||||
Less: Preferred stock dividends |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Preferred stock repurchase premium |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Net income (loss) available to MetLife, Inc.s common shareholders |
$ | 345 | $ | 284 | $ | 189 | $ | 215 | $ | 121 | $ | 1,246 | $ | 809 | ||||||||||||||||
Total Operating Premiums, Fees and Other Revenues |
$ | 2,195 | $ | 2,030 | $ | 2,059 | $ | 2,055 | $ | 2,149 | $ | 8,394 | $ | 8,293 |
12
Table of Contents
AMERICAS RETAIL - ANNUITIES STATEMENTS OF OPERATING EARNINGS AVAILABLE TO COMMON SHAREHOLDERS
|
| |||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Operating revenues |
||||||||||||||||||||||||||||||
Premiums |
$ | 248 | $ | 255 | $ | 225 | $ | 285 | $ | 302 | $ | 1,138 | $ | 1,067 | ||||||||||||||||
Universal life and investment-type product policy fees |
858 | 844 | 868 | 834 | 814 | 3,444 | 3,360 | |||||||||||||||||||||||
Net investment income |
718 | 735 | 728 | 705 | 712 | 2,906 | 2,880 | |||||||||||||||||||||||
Other revenues |
108 | 107 | 110 | 102 | 111 | 437 | 430 | |||||||||||||||||||||||
Total operating revenues |
1,932 | 1,941 | 1,931 | 1,926 | 1,939 | 7,925 | 7,737 | |||||||||||||||||||||||
Operating expenses |
||||||||||||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
396 | 379 | 357 | 526 | 438 | 1,799 | 1,700 | |||||||||||||||||||||||
Interest credited to policyholder account balances |
333 | 315 | 321 | 316 | 316 | 1,341 | 1,268 | |||||||||||||||||||||||
Capitalization of DAC |
(84 | ) | (89 | ) | (98 | ) | (101 | ) | (114 | ) | (335 | ) | (402 | ) | ||||||||||||||||
Amortization of DAC and VOBA |
180 | 165 | 195 | 195 | 152 | 761 | 707 | |||||||||||||||||||||||
Amortization of negative VOBA |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Interest expense on debt |
1 | - | 1 | - | - | 2 | 1 | |||||||||||||||||||||||
Other expenses |
577 | 544 | 586 | 571 | 614 | 2,209 | 2,315 | |||||||||||||||||||||||
Total operating expenses |
1,403 | 1,314 | 1,362 | 1,507 | 1,406 | 5,777 | 5,589 | |||||||||||||||||||||||
Operating earnings before provision for income tax |
529 | 627 | 569 | 419 | 533 | 2,148 | 2,148 | |||||||||||||||||||||||
Provision for income tax expense (benefit) |
144 | 177 | 157 | 79 | 146 | 551 | 559 | |||||||||||||||||||||||
Operating earnings |
385 | 450 | 412 | 340 | 387 | 1,597 | 1,589 | |||||||||||||||||||||||
Preferred stock dividends |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Operating earnings available to common shareholders |
$ | 385 | $ | 450 | $ | 412 | $ | 340 | $ | 387 | $ | 1,597 | $ | 1,589 | ||||||||||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||||||||||||
Operating earnings |
$ | 385 | $ | 450 | $ | 412 | $ | 340 | $ | 387 | $ | 1,597 | $ | 1,589 | ||||||||||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||||||||||||
Net investment gains (losses) |
3 | 67 | (10 | ) | 28 | (23 | ) | 50 | 62 | |||||||||||||||||||||
Net derivative gains (losses) |
(134 | ) | 127 | 15 | (427 | ) | (122 | ) | 272 | (407 | ) | |||||||||||||||||||
Premiums |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Universal life and investment-type product policy fees |
96 | 94 | 95 | 96 | 96 | 378 | 381 | |||||||||||||||||||||||
Net investment income |
(60 | ) | (68 | ) | (46 | ) | (50 | ) | (54 | ) | (235 | ) | (218 | ) | ||||||||||||||||
Other revenues |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
(135 | ) | (113 | ) | (150 | ) | 149 | (284 | ) | (502 | ) | (398 | ) | |||||||||||||||||
Interest credited to policyholder account balances |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Capitalization of DAC |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Amortization of DAC and VOBA |
19 | (43 | ) | 75 | (92 | ) | (16 | ) | (117 | ) | (76 | ) | ||||||||||||||||||
Amortization of negative VOBA |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Interest expense on debt |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Other expenses |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Goodwill impairment |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Provision for income tax (expense) benefit |
73 | (22 | ) | 7 | 103 | 142 | 53 | 230 | ||||||||||||||||||||||
Income (loss) from continuing operations, net of income tax |
247 | 492 | 398 | 147 | 126 | 1,496 | 1,163 | |||||||||||||||||||||||
Income (loss) from discontinued operations, net of income tax |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Net income (loss) |
247 | 492 | 398 | 147 | 126 | 1,496 | 1,163 | |||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
247 | 492 | 398 | 147 | 126 | 1,496 | 1,163 | |||||||||||||||||||||||
Less: Preferred stock dividends |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Preferred stock repurchase premium |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Net income (loss) available to MetLife, Inc.s common shareholders |
$ | 247 | $ | 492 | $ | 398 | $ | 147 | $ | 126 | $ | 1,496 | $ | 1,163 | ||||||||||||||||
Total Operating Premiums, Fees and Other Revenues |
$ | 1,214 | $ | 1,206 | $ | 1,203 | $ | 1,221 | $ | 1,227 | $ | 5,019 | $ | 4,857 |
13
Table of Contents
AMERICAS RETAIL
FUTURE POLICY BENEFITS AND POLICYHOLDER ACCOUNT BALANCES
LIFE & OTHER (1)
|
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions) |
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Balance, beginning of period |
$ | 86,162 | $ | 86,756 | $ | 87,073 | $ | 87,302 | $ | 87,721 | ||||||||||
Premiums and deposits (2), (3) |
1,958 | 2,005 | 1,983 | 1,959 | 2,064 | |||||||||||||||
Surrenders and withdrawals |
(730 | ) | (727 | ) | (758 | ) | (756 | ) | (720 | ) | ||||||||||
Benefit payments |
(637 | ) | (905 | ) | (764 | ) | (800 | ) | (744 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net Flows |
591 | 373 | 461 | 403 | 600 | |||||||||||||||
Net transfers from (to) separate account |
23 | 27 | 19 | 26 | 20 | |||||||||||||||
Interest |
835 | 839 | 852 | 858 | 867 | |||||||||||||||
Policy charges |
(484 | ) | (487 | ) | (489 | ) | (494 | ) | (501 | ) | ||||||||||
Other |
(371 | ) | (435 | ) | (614 | ) | (374 | ) | (545 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, end of period |
$ | 86,756 | $ | 87,073 | $ | 87,302 | $ | 87,721 | $ | 88,162 | ||||||||||
ANNUITIES
|
||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions) |
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Balance, beginning of period |
$ | 47,529 | $ | 47,601 | $ | 47,780 | $ | 47,460 | $ | 50,137 | ||||||||||
Premiums and deposits (2), (3) |
850 | 805 | 909 | 1,123 | 1,177 | |||||||||||||||
Surrenders and withdrawals |
(1,520 | ) | (946 | ) | (851 | ) | (766 | ) | (1,199 | ) | ||||||||||
Benefit payments |
(406 | ) | (428 | ) | (425 | ) | (448 | ) | (424 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net Flows |
(1,076 | ) | (569 | ) | (367 | ) | (91 | ) | (446 | ) | ||||||||||
Net transfers from (to) separate account |
2 | 9 | 51 | 224 | (57 | ) | ||||||||||||||
Interest |
399 | 383 | 391 | 386 | 387 | |||||||||||||||
Policy charges |
(10 | ) | (13 | ) | (14 | ) | (12 | ) | (11 | ) | ||||||||||
Other |
757 | 369 | (381 | ) | 2,170 | (483 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, end of period |
$ | 47,601 | $ | 47,780 | $ | 47,460 | $ | 50,137 | $ | 49,527 | ||||||||||
SEPARATE ACCOUNT LIABILITIES
LIFE & OTHER
|
||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions) |
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Balance, beginning of period |
$ | 9,949 | $ | 10,173 | $ | 10,354 | $ | 10,258 | $ | 9,434 | ||||||||||
Premiums and deposits (3) |
158 | 160 | 160 | 153 | 152 | |||||||||||||||
Surrenders and withdrawals |
(99 | ) | (109 | ) | (112 | ) | (108 | ) | (95 | ) | ||||||||||
Benefit payments |
(11 | ) | (12 | ) | (17 | ) | (45 | ) | (12 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net Flows |
48 | 39 | 31 | - | 45 | |||||||||||||||
Investment performance |
334 | 301 | 27 | (668 | ) | 393 | ||||||||||||||
Net transfers from (to) general account |
(23 | ) | (27 | ) | (19 | ) | (26 | ) | (20 | ) | ||||||||||
Policy charges |
(130 | ) | (132 | ) | (132 | ) | (130 | ) | (132 | ) | ||||||||||
Other |
(5 | ) | - | (3 | ) | - | (2 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, end of period |
$ | 10,173 | $ | 10,354 | $ | 10,258 | $ | 9,434 | $ | 9,718 | ||||||||||
ANNUITIES
|
||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions) |
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Balance, beginning of period |
$ | 160,995 | $ | 161,553 | $ | 163,288 | $ | 159,999 | $ | 147,986 | ||||||||||
Premiums and deposits (3) |
1,370 | 1,384 | 1,626 | 1,503 | 1,542 | |||||||||||||||
Surrenders and withdrawals |
(3,000 | ) | (2,770 | ) | (2,934 | ) | (2,617 | ) | (2,523 | ) | ||||||||||
Benefit payments |
(330 | ) | (347 | ) | (335 | ) | (341 | ) | (299 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net Flows |
(1,960 | ) | (1,733 | ) | (1,643 | ) | (1,455 | ) | (1,280 | ) | ||||||||||
Investment performance |
3,431 | 4,348 | (663 | ) | (9,408 | ) | 4,185 | |||||||||||||
Net transfers from (to) general account |
(2 | ) | (9 | ) | (51 | ) | (224 | ) | 57 | |||||||||||
Policy charges |
(910 | ) | (870 | ) | (933 | ) | (927 | ) | (885 | ) | ||||||||||
Other |
(1 | ) | (1 | ) | 1 | 1 | 1 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, end of period |
$ | 161,553 | $ | 163,288 | $ | 159,999 | $ | 147,986 | $ | 150,064 | ||||||||||
(1) All of the retail property & casualty activity is reflected within the Other category.
(2) Includes premiums and deposits directed to the general account investment option of variable products.
(3) Includes company-sponsored internal exchanges. |
|
14
Table of Contents
15
Table of Contents
AMERICAS RETAIL
VARIABLE & UNIVERSAL LIFE (1)
|
||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Investment income yield excluding variable investment income |
6.13% | 6.01% | 6.29% | 6.13% | 6.11% | |||||||||||||||
Variable investment income yield |
0.38% | 0.32% | 0.39% | 0.18% | (0.29)% | |||||||||||||||
Total investment income yield |
6.51% | 6.33% | 6.68% | 6.31% | 5.82% | |||||||||||||||
Average crediting rate |
4.50% | 4.53% | 4.53% | 4.52% | 4.63% | |||||||||||||||
Annualized general account spread |
2.01% | 1.80% | 2.15% | 1.79% | 1.19% | |||||||||||||||
Annualized general account spread excluding variable investment income yield |
1.63% | 1.48% | 1.76% | 1.61% | 1.48% | |||||||||||||||
ANNUITIES (2)
|
||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Investment income yield excluding variable investment income |
5.64% | 5.72% | 5.48% | 5.38% | 5.46% | |||||||||||||||
Variable investment income yield |
0.22% | 0.22% | 0.37% | 0.19% | 0.07% | |||||||||||||||
Total investment income yield |
5.86% | 5.94% | 5.85% | 5.57% | 5.53% | |||||||||||||||
Average crediting rate |
3.52% | 3.48% | 3.51% | 3.41% | 3.45% | |||||||||||||||
Annualized general account spread |
2.34% | 2.46% | 2.34% | 2.16% | 2.08% | |||||||||||||||
Annualized general account spread excluding variable investment income yield |
2.12% | 2.24% | 1.97% | 1.97% | 2.01% | |||||||||||||||
OTHER STATISTICAL INFORMATION
|
||||||||||||||||||||
For the Three Months Ended | ||||||||||||||||||||
Unaudited (In millions, except ratios) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Life (3) |
||||||||||||||||||||
Operating premiums, fees and other revenues |
$ | 1,499 | $ | 1,370 | $ | 1,386 | $ | 1,396 | $ | 1,504 | ||||||||||
Interest adjusted benefit ratio |
53.9% | 59.3% | 53.0% | 57.4% | 54.9% | |||||||||||||||
Lapse Ratio (4) |
||||||||||||||||||||
Traditional life |
5.9% | 5.8% | 5.6% | 5.4% | 5.3% | |||||||||||||||
Variable & universal life |
3.8% | 3.8% | 3.6% | 3.6% | 3.7% | |||||||||||||||
Fixed annuity |
10.6% | 9.8% | 9.9% | 9.8% | 8.5% | |||||||||||||||
Variable annuity |
6.9% | 7.0% | 7.0% | 7.0% | 6.8% | |||||||||||||||
Retail Property & Casualty |
||||||||||||||||||||
Operating premiums, fees and other revenues |
$ | 458 | $ | 445 | $ | 448 | $ | 448 | $ | 445 | ||||||||||
Combined ratio including catastrophes |
85.8% | 89.3% | 100.1% | 90.9% | 96.1% | |||||||||||||||
Combined ratio excluding catastrophes |
81.5% | 79.4% | 80.2% | 84.0% | 89.4% | |||||||||||||||
(1) Represents the general account spread for variable & universal life, a component of Life & Other.
(2) Represents the general account spread for deferred and payout annuities.
(3) Represents traditional life and variable & universal life, components of Life & Other.
(4) Lapse ratios are calculated based on the average of the most recent 12 months of experience. |
|
16
Table of Contents
17
Table of Contents
18
Table of Contents
19
Table of Contents
20
Table of Contents
21
Table of Contents
22
Table of Contents
23
Table of Contents
24
Table of Contents
25
Table of Contents
26
Table of Contents
27
Table of Contents
28
Table of Contents
29
Table of Contents
30
Table of Contents
INVESTMENTS INVESTMENT PORTFOLIO RESULTS BY ASSET CATEGORY AND ANNUALIZED YIELDS
|
| |||||||||||||||||||
At or For the Year-to-Date Period Ended | ||||||||||||||||||||
Unaudited (In millions, except yields) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | |||||||||||||||
Fixed Maturity Securities |
||||||||||||||||||||
Yield (1) |
4.81% | 4.64% | 4.72% | 4.66% | 4.63% | |||||||||||||||
Investment income (2), (3), (4) |
$ | 14,946 | $ | 3,569 | $ | 7,234 | $ | 10,701 | $ | 14,201 | ||||||||||
Investment gains (losses) (3) |
548 | 133 | 248 | 336 | 114 | |||||||||||||||
Ending carrying value (2), (3) |
366,783 | 367,640 | 352,610 | 352,856 | 352,433 | |||||||||||||||
Mortgage Loans |
||||||||||||||||||||
Yield (1) |
5.15% | 4.80% | 4.95% | 4.95% | 4.97% | |||||||||||||||
Investment income (3), (4) |
2,928 | 730 | 1,531 | 2,316 | 3,135 | |||||||||||||||
Investment gains (losses) (3) |
(36 | ) | (43 | ) | (52 | ) | (78 | ) | (105 | ) | ||||||||||
Ending carrying value (3) |
59,838 | 62,137 | 63,744 | 63,349 | 66,930 | |||||||||||||||
Real Estate and Real Estate Joint Ventures |
||||||||||||||||||||
Yield (1) |
3.67% | 3.10% | 5.23% | 4.83% | 4.89% | |||||||||||||||
Investment income (3) |
376 | 81 | 270 | 371 | 488 | |||||||||||||||
Investment gains (losses) (3) |
217 | 27 | (6 | ) | 257 | 531 | ||||||||||||||
Ending carrying value |
10,525 | 10,310 | 10,207 | 9,923 | 8,433 | |||||||||||||||
Policy Loans |
||||||||||||||||||||
Yield (1) |
5.36% | 5.24% | 5.23% | 5.18% | 5.23% | |||||||||||||||
Investment income |
629 | 152 | 303 | 450 | 603 | |||||||||||||||
Ending carrying value |
11,618 | 11,606 | 11,575 | 11,549 | 11,258 | |||||||||||||||
Equity Securities |
||||||||||||||||||||
Yield (1) |
4.30% | 4.01% | 4.30% | 4.42% | 4.71% | |||||||||||||||
Investment income |
133 | 31 | 66 | 102 | 144 | |||||||||||||||
Investment gains (losses) |
65 | 8 | 16 | 23 | 21 | |||||||||||||||
Ending carrying value |
3,631 | 3,713 | 3,677 | 3,399 | 3,321 | |||||||||||||||
Other Limited Partnership Interests |
||||||||||||||||||||
Yield (1) |
13.01% | 10.62% | 11.50% | 11.27% | 8.45% | |||||||||||||||
Investment income |
1,033 | 215 | 465 | 681 | 669 | |||||||||||||||
Investment gains (losses) |
(78 | ) | 16 | 7 | (52 | ) | (67 | ) | ||||||||||||
Ending carrying value |
8,085 | 8,074 | 8,099 | 7,901 | 7,096 | |||||||||||||||
Cash and Short-term Investments |
||||||||||||||||||||
Yield (1) |
1.07% | 1.00% | 1.02% | 0.93% | 1.04% | |||||||||||||||
Investment income |
161 | 33 | 66 | 89 | 129 | |||||||||||||||
Investment gains (losses) |
11 | 6 | (6 | ) | (6 | ) | (3 | ) | ||||||||||||
Ending carrying value |
19,429 | 22,257 | 22,668 | 25,173 | 22,051 | |||||||||||||||
Other Invested Assets (1) |
||||||||||||||||||||
Investment income |
906 | 327 | 550 | 775 | 1,053 | |||||||||||||||
Investment gains (losses) (3) |
(120 | ) | 18 | (1 | ) | 14 | (7 | ) | ||||||||||||
Ending carrying value |
21,283 | 23,763 | 20,409 | 23,356 | 22,524 | |||||||||||||||
Total Investments |
||||||||||||||||||||
Investment income yield (1) |
5.01% | 4.89% | 4.99% | 4.91% | 4.85% | |||||||||||||||
Investment fees and expenses yield |
(0.13)% | (0.15)% | (0.15)% | (0.15)% | (0.15)% | |||||||||||||||
Net Investment Income Yield (1), (3), (5) |
4.88% | 4.74% | 4.84% | 4.76% | 4.70% | |||||||||||||||
Investment income |
$ | 21,112 | $ | 5,138 | $ | 10,485 | $ | 15,485 | $ | 20,422 | ||||||||||
Investment fees and expenses |
(556 | ) | (156 | ) | (318 | ) | (469 | ) | (633 | ) | ||||||||||
Net investment income including Divested businesses |
20,556 | 4,982 | 10,167 | 15,016 | 19,789 | |||||||||||||||
Less: Net investment income from Divested businesses (5) |
72 | - | - | - | - | |||||||||||||||
Net Investment Income (3) |
$ | 20,484 | $ | 4,982 | $ | 10,167 | $ | 15,016 | $ | 19,789 | ||||||||||
Ending Carrying Value (3) |
$ | 501,192 | $ | 509,500 | $ | 492,989 | $ | 497,506 | $ | 494,046 | ||||||||||
Investment portfolio gains (losses) including Divested businesses |
$ | 607 | $ | 165 | $ | 206 | $ | 494 | $ | 484 | ||||||||||
Less: Investment portfolio gains (losses) from Divested businesses (5) |
2 | - | - | - | - | |||||||||||||||
Investment Portfolio Gains (Losses) (3), (5) |
$ | 605 | $ | 165 | $ | 206 | $ | 494 | $ | 484 | ||||||||||
Gross investment gains |
$ | 1,689 | $ | 445 | $ | 864 | $ | 1,572 | $ | 2,183 | ||||||||||
Gross investment losses |
(789 | ) | (236 | ) | (497 | ) | (863 | ) | (1,354 | ) | ||||||||||
Writedowns |
(295 | ) | (44 | ) | (161 | ) | (215 | ) | (345 | ) | ||||||||||
Investment Portfolio Gains (Losses) (3), (5) |
605 | 165 | 206 | 494 | 484 | |||||||||||||||
Investment portfolio gains (losses) income tax (expense) benefit |
(260 | ) | (52 | ) | 51 | (2 | ) | (116 | ) | |||||||||||
Investment Portfolio Gains (Losses), Net of Income Tax |
$ | 345 | $ | 113 | $ | 257 | $ | 492 | $ | 368 | ||||||||||
Derivative Gains (Losses) including Divested businesses |
$ | 575 | $ | 611 | $ | (492 | ) | $ | (213 | ) | $ | (782 | ) | |||||||
Less: Derivative gains (losses) from Divested businesses (5) |
80 | - | - | - | - | |||||||||||||||
Derivative gains (losses) (3), (5) |
495 | 611 | (492 | ) | (213 | ) | (782 | ) | ||||||||||||
Derivative gains (losses) income tax (expense) benefit |
(199 | ) | (217 | ) | 165 | 55 | 249 | |||||||||||||
Derivative Gains (Losses), Net of Income Tax |
$ | 296 | $ | 394 | $ | (327 | ) | $ | (158 | ) | $ | (533 | ) | |||||||
(1) Yields are calculated as investment income as a percent of average quarterly asset carrying values. Investment income excludes recognized gains and losses and reflects the GAAP adjustments described on Page A-10 and as presented on Page A-1. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets, collateral received from derivative counterparties, the effects of consolidating under GAAP certain VIEs that are treated as CSEs and contractholder-directed unit-linked investments. A yield is not presented for other invested assets, as it is not considered a meaningful measure of performance for this asset class.
(2) Fixed maturity securities includes $1,358 million, $1,365 million, $1,257 million,$1,278 million and $1,031 million in ending carrying value, and $103 million, $37 million, $39 million, $4 million and $21 million of investment income related to fair value option and trading securities at or for the year-to-date period ended December 31, 2014, March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015, respectively.
(3) The reconciliation of the remaining yield table captions to the most directly comparable measures presented in accordance with GAAP are as follows at or for the periods ended December 31, 2014, March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015, respectively: A) Fair value option and trading securities (included within fixed maturity securities above) ending carrying value excludes contractholder-directed unit-linked investments of $15,316 million, $15,091 million, $15,189 million, $14,069 million and $13,981 million; B) Ending carrying value excludes the following effects of consolidating under GAAP certain VIEs that are treated as CSEs: Fair value option and trading securities (included within fixed maturity securities above) of $15 million, $15 million, $14 million, $14 million and $12 million and mortgage loans of $280 million, $272 million, $266 million, $204 million and $172 million; C) Net investment income adjustments as presented on Page A-1; D) Investment portfolio gains (losses) as presented above and the GAAP adjustments as presented below; and E) Derivative gains (losses) as presented above and GAAP adjustments as presented below:
|
| |||||||||||||||||||
For the Year-to-Date Period Ended | ||||||||||||||||||||
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | ||||||||||||||||
Investment portfolio gains (losses) including Divested businesses - in above yield table |
$ | 605 | $ | 165 | $ | 206 | $ | 494 | $ | 484 | ||||||||||
Real estate discontinued operations |
5 | - | - | - | - | |||||||||||||||
Operating joint venture adjustments |
- | (1 | ) | 3 | 6 | 4 | ||||||||||||||
Net investment gains (losses) related to certain CSEs |
5 | (2 | ) | - | (3 | ) | (3 | ) | ||||||||||||
Other gains (losses) reported in net investment gains (losses) on GAAP basis |
(812 | ) | 124 | (56 | ) | 38 | 112 | |||||||||||||
Net investment gains (losses) - GAAP basis |
$ | (197 | ) | $ | 286 | $ | 153 | $ | 535 | $ | 597 | |||||||||
For the Year-to-Date Period Ended | ||||||||||||||||||||
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | ||||||||||||||||
Derivative gains (losses) including Divested businesses - in above yield table |
$ | 575 | $ | 611 | $ | (492 | ) | $ | (213 | ) | $ | (782 | ) | |||||||
Investment hedge adjustments (5) |
705 | 200 | 380 | 574 | 776 | |||||||||||||||
Operating joint venture adjustments |
1 | - | - | - | - | |||||||||||||||
Settlement of foreign currency earnings hedges |
22 | 8 | 17 | 28 | 37 | |||||||||||||||
PAB hedge adjustments |
14 | 2 | 4 | 5 | 7 | |||||||||||||||
Net derivative gains (losses) - GAAP basis |
$ | 1,317 | $ | 821 | $ | (91 | ) | $ | 394 | $ | 38 | |||||||||
(4) Investment income from fixed maturity securities and mortgage loans includes prepayment fees.
(5) Yields are calculated including net investment income of Divested businesses and related carrying values. The net investment income adjustment on Page A-1 for Divested businesses at or for the year-to-date period ended December 31, 2014, March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015, excludes $1 million, $0, $0, $0 and $0, respectively, for the investment hedge adjustment that are included in the investment hedge adjustment line of the derivatives gains (loss) GAAP adjustments reconciliation table presented above. |
|
31
Table of Contents
32
Table of Contents
33
Table of Contents
INVESTMENTS
|
| |||||||||||||||||||||||||||||||||||||||
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | ||||||||||||||||||||||||||||||||||||
Unaudited (In millions) | ||||||||||||||||||||||||||||||||||||||||
Commercial mortgage loans |
$41,088 | $42,164 | $42,953 | $41,619 | $44,012 | |||||||||||||||||||||||||||||||||||
Agricultural mortgage loans |
12,378 | 12,333 | 12,498 | 12,771 | 13,188 | |||||||||||||||||||||||||||||||||||
Residential mortgage loans |
6,677 | 7,955 | 8,618 | 9,270 | 10,048 | |||||||||||||||||||||||||||||||||||
Total Mortgage Loans |
60,143 | 62,452 | 64,069 | 63,660 | 67,248 | |||||||||||||||||||||||||||||||||||
Valuation allowances |
(305) | (315) | (325) | (311) | (318) | |||||||||||||||||||||||||||||||||||
Total Mortgage Loans, net |
$59,838 | $62,137 | $63,744 | $63,349 | $66,930 | |||||||||||||||||||||||||||||||||||
(1) Excludes the effects of consolidating under GAAP certain VIEs that are treated as CSEs. See Page 30, note 3, for the amount excluded for each period presented. |
| |||||||||||||||||||||||||||||||||||||||
SUMMARY OF COMMERCIAL MORTGAGE LOANS BY REGION AND PROPERTY TYPE
|
| |||||||||||||||||||||||||||||||||||||||
December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | ||||||||||||||||||||||||||||||||||||
Unaudited (In millions, except ratios) | Amount | % of Total | Amount | % of Total | Amount | % of Total | Amount | % of Total | Amount | % of Total | ||||||||||||||||||||||||||||||
Pacific |
$ | 8,620 | 21.0% | $ | 9,197 | 21.8% | $ | 9,221 | 21.5% | $ | 9,208 | 22.1% | $ | 9,583 | 21.8% | |||||||||||||||||||||||||
Middle Atlantic |
7,689 | 18.7% | 7,617 | 18.1% | 7,864 | 18.3% | 7,743 | 18.6% | 8,154 | 18.5% | ||||||||||||||||||||||||||||||
International |
7,251 | 17.7% | 7,630 | 18.1% | 7,222 | 16.8% | 7,548 | 18.1% | 7,889 | 17.9% | ||||||||||||||||||||||||||||||
South Atlantic |
6,384 | 15.5% | 6,249 | 14.8% | 6,355 | 14.8% | 5,858 | 14.1% | 6,127 | 13.9% | ||||||||||||||||||||||||||||||
West South Central |
3,990 | 9.7% | 3,939 | 9.3% | 4,404 | 10.3% | 4,289 | 10.3% | 4,311 | 9.8% | ||||||||||||||||||||||||||||||
East North Central |
2,430 | 5.9% | 2,520 | 6.0% | 2,260 | 5.3% | 2,127 | 5.1% | 2,346 | 5.3% | ||||||||||||||||||||||||||||||
New England |
1,155 | 2.8% | 1,151 | 2.7% | 1,352 | 3.1% | 1,350 | 3.2% | 1,367 | 3.1% | ||||||||||||||||||||||||||||||
Mountain |
932 | 2.3% | 1,169 | 2.8% | 1,168 | 2.7% | 1,118 | 2.7% | 1,117 | 2.5% | ||||||||||||||||||||||||||||||
West North Central |
140 | 0.3% | 138 | 0.3% | 150 | 0.3% | 234 | 0.6% | 520 | 1.2% | ||||||||||||||||||||||||||||||
East South Central |
424 | 1.0% | 423 | 1.0% | 390 | 0.9% | 408 | 1.0% | 512 | 1.2% | ||||||||||||||||||||||||||||||
Multi-Region and Other |
2,073 | 5.1% | 2,131 | 5.1% | 2,567 | 6.0% | 1,736 | 4.2% | 2,086 | 4.8% | ||||||||||||||||||||||||||||||
Total |
$ | 41,088 | 100.0% | $ | 42,164 | 100.0% | $ | 42,953 | 100.0% | $ | 41,619 | 100.0% | $ | 44,012 | 100.0% | |||||||||||||||||||||||||
Office |
$ | 21,400 | 52.1% | $ | 21,094 | 50.0 % | $ | 21,334 | 49.7% | $ | 19,951 | 47.9% | $ | 21,525 | 48.9% | |||||||||||||||||||||||||
Retail |
9,389 | 22.9% | 9,543 | 22.6% | 9,982 | 23.2% | 10,002 | 24.0% | 10,466 | 23.8% | ||||||||||||||||||||||||||||||
Apartment |
3,786 | 9.2% | 4,696 | 11.2% | 4,806 | 11.2% | 4,865 | 11.7% | 5,171 | 11.7% | ||||||||||||||||||||||||||||||
Hotel |
4,196 | 10.2% | 4,483 | 10.6% | 4,431 | 10.3% | 4,456 | 10.7% | 4,396 | 10.0% | ||||||||||||||||||||||||||||||
Industrial |
2,133 | 5.2% | 2,157 | 5.1% | 2,205 | 5.1% | 2,191 | 5.3% | 2,334 | 5.3% | ||||||||||||||||||||||||||||||
Other |
184 | 0.4% | 191 | 0.5% | 195 | 0.5% | 154 | 0.4% | 120 | 0.3% | ||||||||||||||||||||||||||||||
Total |
$ | 41,088 | 100.0% | $ | 42,164 | 100.0% | $ | 42,953 | 100.0% | $ | 41,619 | 100.0% | $ | 44,012 | 100.0% |
34
Table of Contents
Table of Contents
METLIFE
|
| |||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Reconciliation to Net Income (Loss) and Financial Statement Line Item Adjustments from GAAP |
||||||||||||||||||||||||||||||
Operating earnings |
$ | 1,614 | $ | 1,668 | $ | 1,796 | $ | 711 | $ | 1,425 | $ | 6,682 | $ | 5,600 | ||||||||||||||||
Adjustments from operating earnings to income (loss) from continuing operations, net of income tax: |
||||||||||||||||||||||||||||||
Net investment gains (losses) (1) |
230 | 286 | (133 | ) | 382 | 62 | (197 | ) | 597 | |||||||||||||||||||||
Net derivative gains (losses) |
185 | 821 | (912 | ) | 485 | (356 | ) | 1,317 | 38 | |||||||||||||||||||||
Premiums - Divested businesses |
5 | - | (1 | ) | (1 | ) | (1 | ) | 45 | (3 | ) | |||||||||||||||||||
Universal life and investment-type product policy fees |
||||||||||||||||||||||||||||||
Unearned revenue adjustments |
6 | 4 | 3 | 1 | (3 | ) | 20 | 5 | ||||||||||||||||||||||
GMIB fees |
96 | 94 | 95 | 96 | 97 | 378 | 382 | |||||||||||||||||||||||
Divested businesses |
1 | 2 | 1 | 2 | 2 | 7 | 7 | |||||||||||||||||||||||
Net investment income |
||||||||||||||||||||||||||||||
Investment hedge adjustments |
(192 | ) | (200 | ) | (180 | ) | (194 | ) | (202 | ) | (704 | ) | (776 | ) | ||||||||||||||||
Income from discontinued real estate operations |
- | - | - | - | - | (1 | ) | - | ||||||||||||||||||||||
Operating joint venture adjustments |
(3 | ) | 1 | (4 | ) | (3 | ) | 2 | (1 | ) | (4 | ) | ||||||||||||||||||
Unit-linked contract income |
527 | 677 | (55 | ) | (701 | ) | 343 | 1,266 | 264 | |||||||||||||||||||||
Securitization entities income |
4 | 1 | 1 | 8 | (2 | ) | 38 | 8 | ||||||||||||||||||||||
Divested businesses |
2 | - | - | - | - | 71 | - | |||||||||||||||||||||||
Other revenues |
||||||||||||||||||||||||||||||
Settlement of foreign currency earnings hedges |
(5 | ) | (8 | ) | (9 | ) | (11 | ) | (9 | ) | (22 | ) | (37 | ) | ||||||||||||||||
Divested businesses |
18 | - | - | - | - | 19 | - | |||||||||||||||||||||||
Policyholder benefits and claims and policyholder dividends |
||||||||||||||||||||||||||||||
PDO adjustments |
6 | 17 | (10 | ) | (13 | ) | - | 6 | (6 | ) | ||||||||||||||||||||
Inflation and pass through adjustments |
(104 | ) | (3 | ) | 25 | (23 | ) | 6 | (260 | ) | 5 | |||||||||||||||||||
GMIB costs |
(134 | ) | (112 | ) | (150 | ) | 149 | (286 | ) | (500 | ) | (399 | ) | |||||||||||||||||
Market value adjustments |
(85 | ) | (51 | ) | (45 | ) | (21 | ) | (19 | ) | (182 | ) | (136 | ) | ||||||||||||||||
Divested businesses |
(3 | ) | - | - | - | (1 | ) | (64 | ) | (1 | ) | |||||||||||||||||||
Interest credited to policyholder account balances |
||||||||||||||||||||||||||||||
PAB hedge adjustments |
(3 | ) | (2 | ) | (2 | ) | (1 | ) | (2 | ) | (14 | ) | (7 | ) | ||||||||||||||||
Unit-linked contract costs |
(534 | ) | (662 | ) | 46 | 685 | (338 | ) | (1,266 | ) | (269 | ) | ||||||||||||||||||
Divested businesses |
(2 | ) | - | - | - | - | (2 | ) | - | |||||||||||||||||||||
Capitalization of DACDivested businesses |
- | - | - | - | - | 1 | - | |||||||||||||||||||||||
Amortization of DAC and VOBA |
||||||||||||||||||||||||||||||
Related to NIGL and NDGL |
(4 | ) | (112 | ) | 104 | (28 | ) | 27 | (41 | ) | (9 | ) | ||||||||||||||||||
Related to GMIB fees and GMIB costs |
(1 | ) | 40 | - | (132 | ) | (33 | ) | (63 | ) | (125 | ) | ||||||||||||||||||
Related to market value adjustments |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Divested businesses |
- | - | - | - | - | (1 | ) | - | ||||||||||||||||||||||
Amortization of negative VOBA |
||||||||||||||||||||||||||||||
Related to market value adjustments |
11 | 10 | 9 | 8 | 8 | 46 | 35 | |||||||||||||||||||||||
Divested businesses |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Interest expense on debt |
||||||||||||||||||||||||||||||
Securitization entities debt expense |
(4 | ) | (1 | ) | (1 | ) | (8 | ) | 2 | (38 | ) | (8 | ) | |||||||||||||||||
Divested businesses |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Other expenses |
||||||||||||||||||||||||||||||
Noncontrolling interest |
12 | 5 | 7 | (11 | ) | 12 | 33 | 13 | ||||||||||||||||||||||
Regulatory implementation costs |
(1 | ) | (1 | ) | (1 | ) | - | - | (3 | ) | (2 | ) | ||||||||||||||||||
Acquisition & integration costs |
(24 | ) | (8 | ) | (7 | ) | (6 | ) | (7 | ) | (55 | ) | (28 | ) | ||||||||||||||||
Divested businesses |
(42 | ) | (1 | ) | (3 | ) | (2 | ) | 6 | (89 | ) | - | ||||||||||||||||||
Goodwill impairment |
- | - | - | - | - | - | - | |||||||||||||||||||||||
Provision for income tax (expense) benefit |
(49 | ) | (302 | ) | 545 | (174 | ) | 109 | (87 | ) | 178 | |||||||||||||||||||
Income (loss) from continuing operations, net of income tax |
1,527 | 2,163 | 1,119 | 1,198 | 842 | 6,339 | 5,322 | |||||||||||||||||||||||
Income (loss) from discontinued operations, net of income tax |
- | - | - | - | - | (3 | ) | - | ||||||||||||||||||||||
Net income (loss) |
1,527 | 2,163 | 1,119 | 1,198 | 842 | 6,336 | 5,322 | |||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests |
6 | 5 | 4 | (5 | ) | 8 | 27 | 12 | ||||||||||||||||||||||
Net income (loss) attributable to MetLife, Inc. |
1,521 | 2,158 | 1,115 | 1,203 | 834 | 6,309 | 5,310 | |||||||||||||||||||||||
Less: Preferred stock dividends |
31 | 30 | 31 | 6 | 49 | 122 | 116 | |||||||||||||||||||||||
Preferred stock repurchase premium |
- | - | 42 | - | - | - | 42 | |||||||||||||||||||||||
Net income (loss) available to MetLife, Inc.s common shareholders |
$ | 1,490 | $ | 2,128 | $ | 1,042 | $ | 1,197 | $ | 785 | $ | 6,187 | $ | 5,152 | ||||||||||||||||
(1) The year ended December 31, 2014 includes a pre-tax net investment loss of $633 million related to the sale of MetLife, Inc.'s wholly-owned subsidiary, MetLife Assurance Limited. |
|
A-1
Table of Contents
APPENDIX METLIFE
|
| |||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (37 | ) | $ | (137 | ) | $ | 136 | $ | (174 | ) | |||||||||||||||
Catastrophe experience and prior year development, net |
16 | (16 | ) | - | 21 | (9 | ) | 33 | (4 | ) | ||||||||||||||||||||||
Actuarial assumption review and other insurance adjustments |
5 | - | - | (92 | ) | - | 77 | (92 | ) | |||||||||||||||||||||||
Litigation reserves & settlement costs |
(117 | ) | - | - | - | - | (174 | ) | - | |||||||||||||||||||||||
Tax adjustments |
27 | - | 61 | (720 | ) | 31 | 18 | (628 | ) | |||||||||||||||||||||||
Total notable items |
$ | (69 | ) | $ | (16 | ) | $ | 61 | $ | (828 | ) | $ | (115 | ) | $ | 90 | $ | (898 | ) | |||||||||||||
RETAIL
|
||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (6 | ) | $ | (57 | ) | $ | 42 | $ | (63 | ) | |||||||||||||||
Catastrophe experience and prior year development, net |
6 | (3 | ) | (2 | ) | 13 | (7 | ) | 9 | 1 | ||||||||||||||||||||||
Actuarial assumption review and other insurance adjustments |
(9 | ) | - | - | (107 | ) | - | 66 | (107 | ) | ||||||||||||||||||||||
Tax adjustments |
- | - | - | 13 | - | 38 | 13 | |||||||||||||||||||||||||
Total notable items |
$ | (3 | ) | $ | (3 | ) | $ | (2 | ) | $ | (87 | ) | $ | (64 | ) | $ | 155 | $ | (156 | ) | ||||||||||||
RETAIL - LIFE & OTHER
|
||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (4 | ) | $ | (47 | ) | $ | 20 | $ | (51 | ) | |||||||||||||||
Catastrophe experience and prior year development, net |
6 | (3 | ) | (2 | ) | 13 | (7 | ) | 9 | 1 | ||||||||||||||||||||||
Actuarial assumption review and other insurance adjustments |
(9 | ) | - | - | (69 | ) | - | 84 | (69 | ) | ||||||||||||||||||||||
Tax adjustments |
- | - | - | (1 | ) | - | 5 | (1 | ) | |||||||||||||||||||||||
Total notable items |
$ | (3 | ) | $ | (3 | ) | $ | (2 | ) | $ | (61 | ) | $ | (54 | ) | $ | 118 | $ | (120 | ) | ||||||||||||
RETAIL - ANNUITIES
|
||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (2 | ) | $ | (10 | ) | $ | 22 | $ | (12 | ) | |||||||||||||||
Actuarial assumption review and other insurance adjustments |
- | - | - | (38 | ) | - | (18 | ) | (38 | ) | ||||||||||||||||||||||
Tax adjustments |
- | - | - | 14 | - | 33 | 14 | |||||||||||||||||||||||||
Total notable items |
$ | - | $ | - | $ | - | $ | (26 | ) | $ | (10 | ) | $ | 37 | $ | (36 | ) | |||||||||||||||
GROUP, VOLUNTARY & WORKSITE BENEFITS |
||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | 11 | $ | (10 | ) | $ | 8 | $ | 1 | |||||||||||||||||
Catastrophe experience and prior year development, net |
10 | (12 | ) | 2 | 8 | (1 | ) | 24 | (3 | ) | ||||||||||||||||||||||
Actuarial assumption review and other insurance adjustments |
(9 | ) | - | - | - | - | (9 | ) | - | |||||||||||||||||||||||
Total notable items |
$ | 1 | $ | (12 | ) | $ | 2 | $ | 19 | $ | (11 | ) | $ | 23 | $ | (2 | ) | |||||||||||||||
(1) Notable items represent a positive (negative) impact to operating earnings available to common shareholders. |
|
A-2
Table of Contents
APPENDIX METLIFE NOTABLE ITEMS (CONTINUED) (1)
|
| |||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | 12 | $ | (9 | ) | $ | 69 | $ | 3 | |||||||||||||||
Tax adjustments |
- | - | - | (1 | ) | - | - | (1 | ) | |||||||||||||||||||||
Total notable items |
$ | - | $ | - | $ | - | $ | 11 | $ | (9 | ) | $ | 69 | $ | 2 | |||||||||||||||
LATIN AMERICA
|
||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (2 | ) | $ | (3 | ) | $ | - | $ | (5 | ) | |||||||||||||
Catastrophe experience and prior year development, net |
- | (1 | ) | - | - | (1 | ) | - | (2 | ) | ||||||||||||||||||||
Tax adjustments |
13 | - | - | 60 | 31 | (28 | ) | 91 | ||||||||||||||||||||||
Total notable items |
$ | 13 | $ | (1 | ) | $ | - | $ | 58 | $ | 27 | $ | (28 | ) | $ | 84 | ||||||||||||||
ASIA
|
||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (10 | ) | $ | (24 | ) | $ | 3 | $ | (34 | ) | |||||||||||||
Actuarial assumption review and other insurance adjustments |
23 | - | - | 9 | - | 10 | 9 | |||||||||||||||||||||||
Tax adjustments |
- | - | 61 | - | - | - | 61 | |||||||||||||||||||||||
Total notable items |
$ | 23 | $ | - | $ | 61 | $ | (1 | ) | $ | (24 | ) | $ | 13 | $ | 36 | ||||||||||||||
EMEA
|
||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Actuarial assumption review and other insurance adjustments |
$ | - | $ | - | $ | - | $ | 6 | $ | - | $ | 10 | $ | 6 | ||||||||||||||||
Tax adjustments |
14 | - | - | - | - | 14 | - | |||||||||||||||||||||||
Total notable items |
$ | 14 | $ | - | $ | - | $ | 6 | $ | - | $ | 24 | $ | 6 | ||||||||||||||||
CORPORATE & OTHER
|
||||||||||||||||||||||||||||||
For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||
Unaudited (In millions) | December 31, 2014 | March 31, 2015 | June 30, 2015 | September 30, 2015 | December 31, 2015 | December 31, 2014 | December 31, 2015 | |||||||||||||||||||||||
Variable investment income, as compared to plan |
$ | - | $ | - | $ | - | $ | (42 | ) | $ | (34 | ) | $ | 14 | $ | (76 | ) | |||||||||||||
Litigation reserves & settlement costs |
(117 | ) | - | - | - | - | (174 | ) | - | |||||||||||||||||||||
Tax adjustments |
- | - | - | (792 | ) | - | (6 | ) | (792 | ) | ||||||||||||||||||||
Total notable items |
$ | (117 | ) | $ | - | $ | - | $ | (834 | ) | $ | (34 | ) | $ | (166 | ) | $ | (868 | ) | |||||||||||
(1) Notable items represent a positive (negative) impact to operating earnings available to common shareholders. |
|
A-3
Table of Contents
A-4
Table of Contents
A-5
Table of Contents
A-6
Table of Contents
A-7
Table of Contents
A-8
Table of Contents
A-9
Table of Contents
Non-GAAP financial measures: | Comparable GAAP financial measures: | |||||||
(i) |
operating revenues |
(i) |
GAAP revenues | |||||
(ii) |
operating expenses |
(ii) |
GAAP expenses | |||||
(iii) |
operating earnings |
(iii) |
income (loss) from continuing operations, net of income tax | |||||
(iv) |
operating earnings available to common shareholders |
(iv) |
net income (loss) available to MetLife, Inc.s common shareholders | |||||
(v) |
operating earnings available to common shareholders per diluted common share |
(v) |
net income (loss) available to MetLife, Inc.s common shareholders per diluted common share | |||||
(vi) |
investment portfolio gains (losses) |
(vi) |
net investment gains (losses) | |||||
(vii) |
derivative gains (losses) |
(vii) |
net derivative gains (losses) | |||||
(viii) |
MetLife, Inc.s tangible common stockholders equity |
(viii) |
MetLife, Inc.s stockholders equity | |||||
(ix) |
MetLife, Inc.s common stockholders equity, excluding AOCI other than FCTA |
(ix) |
MetLife, Inc.s stockholders equity |
Reconciliations of these measures to the most directly comparable GAAP measures are included in this QFS and in this periods earnings news release which is available at www.metlife.com.
Our definitions of the various non-GAAP and other financial measures discussed in this QFS may differ from those used by other companies:
Operating earnings is the measure of segment profit or loss we use to evaluate segment performance and allocate resources. Consistent with GAAP accounting guidance for segment reporting, operating earnings is our measure of segment performance. Operating earnings is also a measure by which senior managements and many other employees performance is evaluated for the purposes of determining their compensation under applicable compensation plans.
Operating earnings is defined as operating revenues less operating expenses, both net of income tax. Operating earnings available to common shareholders is defined as operating earnings less preferred stock dividends.
Operating revenues and operating expenses exclude results of discontinued operations and other businesses that have been or will be sold or exited by MetLife (Divested businesses). Operating revenues also excludes NIGL and NDGL. Operating expenses also excludes goodwill impairments.
The following additional adjustments are made to GAAP revenues, in the line items indicated, in calculating operating revenues: | ||||||
|
Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to NIGL and NDGL (Unearned revenue adjustments) and certain variable annuity GMIB fees (GMIB fees); | |||||
|
Net investment income: (i) includes amounts for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments but do not qualify for hedge accounting treatment (Investment hedge adjustments), (ii) includes income from discontinued real estate operations, (iii) excludes post-tax operating earnings adjustments relating to insurance joint ventures accounted for under the equity method (Operating joint venture adjustments), (iv) excludes certain amounts related to contractholder-directed unit-linked investments (Unit-linked contract income), and (v) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP (Securitization entities income); and | |||||
|
Other revenues are adjusted for settlements of foreign currency earnings hedges. | |||||
The following additional adjustments are made to GAAP expenses, in the line items indicated, in calculating operating expenses: | ||||||
|
Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to NIGL and NDGL (PDO adjustments), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass through adjustments (Inflation and pass through adjustments), (iii) benefits and hedging costs related to GMIBs (GMIB costs), and (iv) market value adjustments associated with surrenders or terminations of contracts (Market value adjustments); | |||||
|
Interest credited to policyholder account balances includes adjustments for scheduled periodic settlement payments and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment (PAB hedge adjustments) and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments (Unit-linked contract costs); | |||||
|
Amortization of DAC and VOBA excludes amounts related to: (i) NIGL and NDGL, (ii) GMIB fees and GMIB costs, and (iii) Market value adjustments; | |||||
|
Amortization of negative VOBA excludes amounts related to Market value adjustments; | |||||
|
Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP (Securitization entities debt expense); and | |||||
|
Other expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements (Regulatory implementation costs), and (iii) acquisition and integration costs. | |||||
Operating earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance. In addition to the tax impact of the adjustments mentioned above, provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms. |
A-10
Table of Contents
METLIFE NON-GAAP AND OTHER FINANCIAL DISCLOSURES (CONTINUED)
The following additional information is relevant to an understanding of our performance results: | ||
|
MetLife, Inc.s tangible common stockholders equity or tangible equity - MetLife, Inc.s common stockholders equity, excluding the net unrealized investment gains (losses) and defined benefit plans adjustment components of AOCI reduced by the impact of goodwill, VODA and VOCRA, all net of income tax. | |
|
MetLife, Inc.s common stockholders equity, excluding AOCI other than FCTA - MetLife, Inc.s common stockholders equity, excluding the net unrealized investment gains (losses) and defined benefit plans adjustment components of AOCI, net of income tax. | |
|
Allocated equity - portion of MetLife, Inc.s common stockholders equity that management allocates to each of its segments and sub-segments based on local capital requirements and economic capital. Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. MetLife management periodically reviews this model to ensure that it remains consistent with emerging industry practice standards and the local capital requirements; allocated equity may be adjusted if warranted by such review. Allocated equity excludes the impact of AOCI other than FCTA. | |
|
Operating return on MetLife, Inc.s common stockholders equity, excluding AOCI other than FCTA - operating earnings available to common shareholders divided by MetLife, Inc.s average common stockholders equity, excluding AOCI other than FCTA. | |
|
Operating return on MetLife, Inc.s tangible common stockholders equity - operating earnings available to common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by MetLife, Inc.s average tangible common stockholders equity. | |
|
Operating return on MetLife, Inc.s common stockholders equity - operating earnings available to common shareholders divided by MetLife, Inc.s average common stockholders equity. | |
|
Return on MetLife, Inc.s common stockholders equity, excluding AOCI other than FCTA - net income (loss) available to MetLife, Inc.s common shareholders divided by MetLife, Inc.s average common stockholders equity, excluding AOCI other than FCTA. | |
|
Return on MetLife, Inc.s tangible common stockholders equity - net income (loss) available to MetLife, Inc.s common shareholders, excluding goodwill impairment and amortization of VODA and VOCRA, net of income tax, divided by MetLife, Inc.s average tangible common stockholders equity. | |
|
Return on MetLife, Inc.s common stockholders equity - net income (loss) available to MetLife, Inc.s common shareholders divided by MetLife, Inc.s average common stockholders equity. | |
|
Operating return on allocated equity - operating earnings available to common shareholders divided by allocated equity. | |
|
Operating return on allocated tangible equity - operating earnings available to common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by allocated tangible equity. | |
|
Return on allocated equity - net income (loss) available to MetLife, Inc.s common shareholders divided by allocated equity. | |
|
Return on allocated tangible equity - net income (loss) available to MetLife, Inc.s common shareholders, excluding amortization of VODA and VOCRA, net of income tax, divided by allocated tangible equity. | |
|
Statistical sales information for Retail - Life sales are calculated using the LIMRA definition of sales for core direct sales, excluding company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life insurance. Annuity sales consist of statutory premiums direct and assumed, excluding company sponsored internal exchanges. Sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity. | |
|
Statistical sales information for Latin America, Asia and EMEA - calculated using 10% of single-premium deposits (mainly from retirement products such as variable annuity, fixed annuity and pensions), 20% of single-premium deposits from credit insurance and 100% of annualized full-year premiums and fees from recurring-premium policy sales of all products (mainly from risk and protection products such as individual life, accident & health and group). Sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity. | |
|
All comparisons on a constant currency basis reflect the impact of changes in foreign currency exchange rates and are calculated using the average foreign currency exchange rates for the current period and are applied to each of the comparable periods. As a result, amounts will be updated each period to reflect the average foreign currency exchange. |
A-11
Table of Contents
METLIFE | ||
AOCI |
Accumulated other comprehensive income (loss) | |
CSE |
Consolidated securitization entity | |
DAC |
Deferred policy acquisition costs | |
EMEA |
Europe, the Middle East and Africa | |
FCTA |
Foreign currency translation adjustments | |
GAAP |
Accounting principles generally accepted in the United States of America | |
GMIB |
Guaranteed minimum income benefits | |
LTC |
Long-term care | |
NAIC |
National Association of Insurance Commissioners | |
NDGL |
Net derivative gains (losses) | |
NIGL |
Net investment gains (losses) | |
PDO |
Policyholder dividend obligation | |
PAB |
Policyholder account balances | |
QFS |
Quarterly financial supplement | |
VIE |
Variable interest entity | |
VOBA |
Value of business acquired | |
VOCRA |
Value of customer relationships acquired | |
VODA |
Value of distribution agreements |
A-12
Table of Contents